Traws Pharma, Inc. (TRAW) stock
TRAWNasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.25−0.03 (-11.87%)
Close on Nov 13, 2026Market cap $3.86MP/E –Yield –
Traws Pharma profit margin
Profit margin (net margin) is net income as a percentage of revenue.
Traws Pharma's profit margin for the twelve months ending Dec 31, 2025 was 328.7%. For fiscal 2025 it was 328.7%, against -73682.7% the year before. The highest annual figure on record is 328.7% in fiscal 2025.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 328.7% | +74011.4 |
| FY2024 | Dec 31, 2024 | -73682.7% | −65298.7 |
| FY2023 | Dec 31, 2023 | -8384.1% | +7.1 |
| FY2022 | Dec 31, 2022 | -8391.2% | −1239.4 |
| FY2021 | Dec 31, 2021 | -7151.8% | +3738.7 |
| FY2020 | Dec 31, 2020 | -10890.5% | −9905.5 |
| FY2019 | Dec 31, 2019 | -985.0% | +690.3 |
| FY2018 | Dec 31, 2018 | -1675.3% | +1385.9 |
| FY2017 | Dec 31, 2017 | -3061.2% | −2706.6 |
| FY2016 | Dec 31, 2016 | -354.6% | −145.3 |
| FY2015 | Dec 31, 2015 | -209.3% | +7750.9 |
| FY2014 | Dec 31, 2014 | -7960.3% | −6644.4 |
| FY2013 | Dec 31, 2013 | -1315.9% | −1251.1 |
| FY2012 | Dec 31, 2012 | -64.8% | +1703.5 |
| FY2011 | Dec 31, 2011 | -1768.3% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2025 | Jun 30, 2025 | -33.5% | +216006.9 |
| Q1 FY2025 | Mar 31, 2025 | 37701.8% | +46600.0 |
| Q4 FY2024 | Dec 31, 2024 | -53432.1% | −45960.7 |
| Q3 FY2024 | Sep 30, 2024 | -14868.4% | −6554.4 |
| Q2 FY2024 | Jun 30, 2024 | -216040.4% | −208584.2 |
| Q1 FY2024 | Mar 31, 2024 | -8898.2% | +10258.5 |
| Q4 FY2023 | Dec 31, 2023 | -7471.4% | −177.8 |
| Q3 FY2023 | Sep 30, 2023 | -8314.0% | −8137.9 |
| Q2 FY2023 | Jun 30, 2023 | -7456.1% | +3720.3 |
| Q4 FY2019 | Dec 31, 2019 | -19156.7% | −9578.7 |
| Q3 FY2019 | Sep 30, 2019 | -7293.7% | −2837.0 |
| Q2 FY2019 | Jun 30, 2019 | -176.1% | +748.4 |
| Q1 FY2019 | Mar 31, 2019 | -11176.5% | −10274.0 |
| Q4 FY2018 | Dec 31, 2018 | -9578.0% | −5237.4 |
| Q3 FY2018 | Sep 30, 2018 | -4456.7% | +1871.5 |
| Q2 FY2018 | Jun 30, 2018 | -924.5% | −127.0 |
| Q1 FY2018 | Mar 31, 2018 | -902.5% | +3069.4 |
| Q4 FY2017 | Dec 31, 2017 | -4340.6% | −1192.0 |
| Q3 FY2017 | Sep 30, 2017 | -6328.2% | −6231.3 |
| Q2 FY2017 | Jun 30, 2017 | -797.5% | – |
| Q1 FY2017 | Mar 31, 2017 | -3971.9% | – |
| Q4 FY2016 | Dec 31, 2016 | -3148.6% | – |
| Q3 FY2016 | Sep 30, 2016 | -96.9% | – |
See a number that looks wrong?